JP2008545700A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545700A5
JP2008545700A5 JP2008513703A JP2008513703A JP2008545700A5 JP 2008545700 A5 JP2008545700 A5 JP 2008545700A5 JP 2008513703 A JP2008513703 A JP 2008513703A JP 2008513703 A JP2008513703 A JP 2008513703A JP 2008545700 A5 JP2008545700 A5 JP 2008545700A5
Authority
JP
Japan
Prior art keywords
group
ether
compound represented
atom
ether group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008513703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/020226 external-priority patent/WO2006127893A2/en
Publication of JP2008545700A publication Critical patent/JP2008545700A/ja
Publication of JP2008545700A5 publication Critical patent/JP2008545700A5/ja
Pending legal-status Critical Current

Links

JP2008513703A 2005-05-25 2006-05-25 ４−（ビフェニリル）アゼチジン−２−オンホスホン酸類の製造方法 Pending JP2008545700A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68448105P 2005-05-25 2005-05-25
PCT/US2006/020226 WO2006127893A2 (en) 2005-05-25 2006-05-25 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids

Publications (2)

Publication Number Publication Date
JP2008545700A JP2008545700A (ja) 2008-12-18
JP2008545700A5 true JP2008545700A5 (enExample) 2009-07-30

Family

ID=37103301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008513703A Pending JP2008545700A (ja) 2005-05-25 2006-05-25 ４−（ビフェニリル）アゼチジン−２−オンホスホン酸類の製造方法

Country Status (15)

Country Link
US (1) US20090099355A1 (enExample)
EP (1) EP1896135A2 (enExample)
JP (1) JP2008545700A (enExample)
KR (1) KR20080025077A (enExample)
CN (1) CN101222950A (enExample)
AU (1) AU2006249905A1 (enExample)
BR (1) BRPI0611415A2 (enExample)
CA (1) CA2609506A1 (enExample)
EA (1) EA200702614A1 (enExample)
IL (1) IL187626A0 (enExample)
MA (1) MA29553B1 (enExample)
NO (1) NO20076597L (enExample)
TW (1) TW200801027A (enExample)
WO (1) WO2006127893A2 (enExample)
ZA (1) ZA200710857B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
EP1682499B1 (en) * 2003-11-10 2007-08-08 Microbia, Inc. 4-biarylyl-1-phenylazetidin-2-ones
WO2005061452A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
EP1831162B1 (en) 2004-12-20 2012-10-31 Merck Sharp & Dohme Corp. Process for the synthesis of azetidinones
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
DE102005055726A1 (de) * 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
BRPI0715160A2 (pt) 2006-08-08 2013-06-11 Sanofi Aventis imidazolidina-2,4-dionas substituÍdas por arilamimoaril-alquil-, processo para preparÁ-las, medicamentos compeendendo estes compostos, e seu uso
WO2008061238A2 (en) * 2006-11-16 2008-05-22 Ironwood Pharmaceuticals, Inc. Processes for production of 4-biphenylyazetidin-2-ones
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007054497B3 (de) 2007-11-13 2009-07-23 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung
WO2009157019A2 (en) * 2008-06-23 2009-12-30 Ind-Swift Laboratories Limited Process for preparing ezetimibe using novel allyl intermediates
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
ES2443016T3 (es) 2009-08-26 2014-02-17 Sanofi Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
CN102285932B (zh) * 2011-09-01 2013-06-12 浙江大学 一种依替米贝中间体的制备方法
AU2012362698B2 (en) * 2011-12-30 2017-08-24 Corteva Agriscience Llc Methods of forming 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol esters and methods of using the same
CN103396429B (zh) * 2013-06-28 2016-05-25 杭州师范大学 一种硅手性中心的硅烷衍生物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE158789T1 (de) * 1991-07-23 1997-10-15 Schering Corp Substituierte beta-lactam-verbindungen als hypocholesterolemische mittel und verfahren zu deren herstellung
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
CA2158191A1 (en) * 1994-09-16 1996-03-17 Junji Yokoi Method for preventing settlement of aquatic fouling organisms
CA2353981C (en) * 1998-12-07 2005-04-26 Schering Corporation Process for the synthesis of azetidinones
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
BR0116325A (pt) * 2000-12-21 2003-10-14 Aventis Pharma Gmbh 1,2-difenilazetidinonas, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação para o tratamento de distúrbios do metabolismo de lipìdios
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
US6627757B2 (en) * 2001-03-28 2003-09-30 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
EP1626954A2 (en) * 2003-05-05 2006-02-22 Ranbaxy Laboratories, Ltd. Process for the preparation of trans-isomers of diphenylazetidinone derivatives
EP1682499B1 (en) * 2003-11-10 2007-08-08 Microbia, Inc. 4-biarylyl-1-phenylazetidin-2-ones
WO2006086562A2 (en) * 2005-02-09 2006-08-17 Microbia, Inc. Phenylazetidinone derivatives
TW200726746A (en) * 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones
BRPI0608970A2 (pt) * 2005-05-11 2010-02-17 Microbia Inc processos para produção de 4-bifenililazetidin-2-onas fenólicas

Similar Documents

Publication Publication Date Title
JP2008545700A5 (enExample)
JP2008540557A5 (enExample)
JP2007524706A5 (enExample)
JP2013520495A5 (enExample)
RU2013114370A (ru) Производные эфиров фосфоновых кислот и способы их синтеза
JP2017210484A5 (enExample)
JP2004528385A5 (enExample)
JP2004504323A5 (enExample)
JP5115477B2 (ja) 水酸基を有する３−エチルオキセタン化合物及びその製法
JP2011507941A5 (enExample)
JP2008526897A5 (enExample)
JP6634428B2 (ja) ピリミジニルシクロペンタン化合物の調製方法
JP2008542205A5 (enExample)
JP2006514956A5 (enExample)
ES2295965T3 (es) Procedimiento para la obtencion de tolterodina.
JP5257353B2 (ja) 置換ヒドロキシメチルフェノールの新規な合成
JP2014520796A5 (enExample)
RU2007104036A (ru) Способ получения диизопропил (гидроксиметил)-циклопропил)окси) метилфосфоната
US6777554B2 (en) Preparation of N-methylparoxetine and related intermediate compounds
JP4018546B2 (ja) ３−（ｚ）−プロペニルセフェム化合物の選択的な製造方法
JP2008231223A (ja) 新規なオキセタン化ノボラック樹脂及びその製法
JP2002516895A (ja) 保護ジヒドロキシプロピルトリアルキルアンモニウム塩およびそれらの誘導体の調製方法
ES2522549T3 (es) Procedimiento para la preparación de 2-hidroxi-4-fenil-3,4-dihidro-2H-cromen-6-il-metanol y (R)-feso-deacilo
JP2004505073A (ja) 鎮咳活性を有する１，３−ジオキソラン
JP4518318B2 (ja) ベンゾ［ｃ］フェナンスリジン誘導体の新規製造法